Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NEWRON-PHARMACEUTICALS-S--198001/news/Newron-Pharmaceuticals-Receives-FDA-Orphan-Drug-Designation-for-Sarizotan-for-the-Treatment-of-Ret-20685789/?utm_source=whatsapp&utm_medium=social&utm_campaign=share